HealthTechX Asia
HealthTechX Asia 2025
Trade Event Partnership Program, May 21-22 2025, Sands Expo & Convention Centre, Singapore

Trade Event Partnership Program at HealthTechX Asia 2025

The US Commercial Service is partnering with HealthTechX Asia 2025 in Singapore May 21-22, 2025 through the Trade Events Partnership Program. 

US Companies are well positioned to enter Asia’s health technology market, projected to be worth USD143B in 2024 with a CAGR of 23.3% to 2033 compared to a 4.83% CAGR in the US or 15% CAGR globally. By participating in HealthTechX Asia, U.S. companies can leverage a world-class platform to build relationships, gain insights, and drive business growth in one of the most dynamic healthcare markets globally.

Check out our recent webinar recording: Access to Asia’s Rapidly Growing Health Technology Market to learn more about market entry! 

Hear from Dr Stephanie Ko, a consultant in Advanced Internal Medicine at the National University Hospital. With an interest in improving delivery of healthcare to the evolving population, she has been serving as the Lead for NUHS@Home since 2020 to deliver hospital-level care beyond the hospital walls at NUHS. Alongside the development of the clinical service, Dr. Ko also leads a collaborative research group to evaluate the implementation and scaling of Hospital-at-Home care models. 

Also featuring Feras Mahdi, a Partner at L.E.K., a global management consulting firm, with over 20 years of experience in healthcare and consulting across 25+ countries, primarily in APAC and MEA. He advises global MedTech companies and large healthcare institutions on corporate and business strategies, and works closely with governments and international agencies on public health policies, particularly around technology deployment and its impact. In addition to his corporate work, Dr. Mahdi mentors multiple startups, helping foster innovation in healthcare. Dr. Mahdi has held leadership roles at multinational MedTech companies like Medtronic and GE Healthcare, and led the APAC MedTech practice at IQVIA, an international healthcare & life sciences consulting firm. He is currently based in Singapore. He holds an MD with a specialization in Internal Medicine from the American University of Beirut and a Masters in BioScience Enterprise from the Judge Business School, University of Cambridge.

 

More Information


Copy Link Copy Link

Our team will be at the show May 21-22, 2025. Visit us at our booth where we’ll be happy to discuss how the U.S. Commercial Service can help you export to new markets.

U.S. companies, please email: Monica Toporkiewicz or Luanne Theseira

For more information on Exhibiting at HealthTechX Asia please email: Adrian Sng

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility